480 related articles for article (PubMed ID: 32649367)
1. Potential Immunotherapeutic Targets for Hypoxia Due to COVI-Flu.
Leyfman Y; Erick TK; Reddy SS; Galwankar S; Nanayakkara PWB; Di Somma S; Sharma P; Stawicki SP; Chaudry IH
Shock; 2020 Oct; 54(4):438-450. PubMed ID: 32649367
[TBL] [Abstract][Full Text] [Related]
2. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents.
Khadke S; Ahmed N; Ahmed N; Ratts R; Raju S; Gallogly M; de Lima M; Sohail MR
Virol J; 2020 Oct; 17(1):154. PubMed ID: 33059711
[TBL] [Abstract][Full Text] [Related]
3. Coinfection with SARS-CoV-2 and influenza A virus.
Kondo Y; Miyazaki S; Yamashita R; Ikeda T
BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32611659
[TBL] [Abstract][Full Text] [Related]
4. The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19.
Xu Y; Baylink DJ; Chen CS; Reeves ME; Xiao J; Lacy C; Lau E; Cao H
J Transl Med; 2020 Aug; 18(1):322. PubMed ID: 32847594
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics.
Qin H; Zhao A
Protein Cell; 2020 Oct; 11(10):707-722. PubMed ID: 32519302
[TBL] [Abstract][Full Text] [Related]
6. Management of Respiratory Distress Syndrome due to COVID-19 infection.
Navas-Blanco JR; Dudaryk R
BMC Anesthesiol; 2020 Jul; 20(1):177. PubMed ID: 32689937
[TBL] [Abstract][Full Text] [Related]
7. COVID-19: immunopathogenesis and Immunotherapeutics.
Yang L; Liu S; Liu J; Zhang Z; Wan X; Huang B; Chen Y; Zhang Y
Signal Transduct Target Ther; 2020 Jul; 5(1):128. PubMed ID: 32712629
[TBL] [Abstract][Full Text] [Related]
8. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports.
Najjar S; Najjar A; Chong DJ; Pramanik BK; Kirsch C; Kuzniecky RI; Pacia SV; Azhar S
J Neuroinflammation; 2020 Aug; 17(1):231. PubMed ID: 32758257
[TBL] [Abstract][Full Text] [Related]
9. The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response.
Arnaldez FI; O'Day SJ; Drake CG; Fox BA; Fu B; Urba WJ; Montesarchio V; Weber JS; Wei H; Wigginton JM; Ascierto PA
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32385146
[TBL] [Abstract][Full Text] [Related]
10. The pathogenesis and treatment of the `Cytokine Storm' in COVID-19.
Ye Q; Wang B; Mao J
J Infect; 2020 Jun; 80(6):607-613. PubMed ID: 32283152
[TBL] [Abstract][Full Text] [Related]
11. AhR and IDO1 in pathogenesis of Covid-19 and the "Systemic AhR Activation Syndrome:" a translational review and therapeutic perspectives.
Turski WA; Wnorowski A; Turski GN; Turski CA; Turski L
Restor Neurol Neurosci; 2020; 38(4):343-354. PubMed ID: 32597823
[TBL] [Abstract][Full Text] [Related]
12. Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome: A Cautionary Case Report.
Radbel J; Narayanan N; Bhatt PJ
Chest; 2020 Jul; 158(1):e15-e19. PubMed ID: 32343968
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular disease during the COVID-19 pandemic: Think ahead, protect hearts, reduce mortality.
Li G; Saguner AM; An J; Ning Y; Day JD; Ding L; Waintraub X; Wang J
Cardiol J; 2020; 27(5):616-624. PubMed ID: 32789839
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Infection and High-Risk Non-Muscle-Invasive Bladder Cancer: Are There Any Common Features?
Busetto GM; Porreca A; Del Giudice F; Maggi M; D'Agostino D; Romagnoli D; Musi G; Lucarelli G; Palmer K; Colonna di Paliano A; Muto M; Hurle R; Terracciano D; de Cobelli O; Sciarra A; De Berardinis E; Ferro M
Urol Int; 2020; 104(7-8):510-522. PubMed ID: 32516772
[TBL] [Abstract][Full Text] [Related]
15. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions.
Jamilloux Y; Henry T; Belot A; Viel S; Fauter M; El Jammal T; Walzer T; François B; Sève P
Autoimmun Rev; 2020 Jul; 19(7):102567. PubMed ID: 32376392
[TBL] [Abstract][Full Text] [Related]
16. Applying the Lessons of Influenza to COVID-19 During a Time of Uncertainty.
Vardeny O; Madjid M; Solomon SD
Circulation; 2020 May; 141(21):1667-1669. PubMed ID: 32208975
[No Abstract] [Full Text] [Related]
17. Cardiac and arrhythmic complications in patients with COVID-19.
Kochi AN; Tagliari AP; Forleo GB; Fassini GM; Tondo C
J Cardiovasc Electrophysiol; 2020 May; 31(5):1003-1008. PubMed ID: 32270559
[TBL] [Abstract][Full Text] [Related]
18. Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity.
Pasquarelli-do-Nascimento G; Braz-de-Melo HA; Faria SS; Santos IO; Kobinger GP; Magalhães KG
Front Endocrinol (Lausanne); 2020; 11():530. PubMed ID: 32849309
[TBL] [Abstract][Full Text] [Related]
19. A Collaborative Multidisciplinary Approach to the Management of Coronavirus Disease 2019 in the Hospital Setting.
Razonable RR; Pennington KM; Meehan AM; Wilson JW; Froemming AT; Bennett CE; Marshall AL; Virk A; Carmona EM
Mayo Clin Proc; 2020 Jul; 95(7):1467-1481. PubMed ID: 32622450
[TBL] [Abstract][Full Text] [Related]
20. Severe COVID-19 and aging: are monocytes the key?
Pence BD
Geroscience; 2020 Aug; 42(4):1051-1061. PubMed ID: 32556942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
